124 related articles for article (PubMed ID: 29056148)
1. Neuropeptides and Addiction: An Introduction.
Thiele TE
Int Rev Neurobiol; 2017; 136():1-3. PubMed ID: 29056148
[TBL] [Abstract][Full Text] [Related]
2. Circuit and neuropeptide mechanisms of the paraventricular thalamus across stages of alcohol and drug use.
Hartmann MC; Pleil KE
Neuropharmacology; 2021 Oct; 198():108748. PubMed ID: 34389397
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide modulation of addiction: Focus on galanin.
Genders SG; Scheller KJ; Djouma E
Neurosci Biobehav Rev; 2020 Mar; 110():133-149. PubMed ID: 29949733
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic neuropeptide signaling in alcohol addiction.
Barson JR; Leibowitz SF
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():321-9. PubMed ID: 25689818
[TBL] [Abstract][Full Text] [Related]
5. The role of neuropeptides in drug and ethanol abuse: Medication targets for drug and alcohol use disorders.
Barson JR
Brain Res; 2020 Aug; 1740():146876. PubMed ID: 32387136
[No Abstract] [Full Text] [Related]
6. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
7. Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission.
Quarta D; Smolders I
Eur J Pharm Sci; 2014 Jun; 57():2-10. PubMed ID: 24472703
[TBL] [Abstract][Full Text] [Related]
8. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
Valdez GR; Koob GF
Pharmacol Biochem Behav; 2004 Dec; 79(4):671-89. PubMed ID: 15582675
[TBL] [Abstract][Full Text] [Related]
9. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission.
Cannella N; Kallupi M; Ruggeri B; Ciccocioppo R; Ubaldi M
Prog Neurobiol; 2013 Jan; 100():48-59. PubMed ID: 23041581
[TBL] [Abstract][Full Text] [Related]
10. A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders.
Robinson SL; Thiele TE
Neuropharmacology; 2020 May; 167():107983. PubMed ID: 32027909
[TBL] [Abstract][Full Text] [Related]
11. Cocaine and nicotine research illustrates a range of hypocretin mechanisms in addiction.
Baimel C; Borgland SL; Corrigall W
Vitam Horm; 2012; 89():291-313. PubMed ID: 22640620
[TBL] [Abstract][Full Text] [Related]
12. Stress, alcohol and drug interaction: an update of human research.
Uhart M; Wand GS
Addict Biol; 2009 Jan; 14(1):43-64. PubMed ID: 18855803
[TBL] [Abstract][Full Text] [Related]
13. [Role of endogenous neuropeptides in the pathomechanism of alcohol addiction].
Rudzińska U; Zalewska-Kaszubska J
Postepy Hig Med Dosw (Online); 2009 Dec; 63():643-52. PubMed ID: 20097951
[TBL] [Abstract][Full Text] [Related]
14. The Role of Neuropeptide Y (NPY) in Alcohol and Drug Abuse Disorders.
Robinson SL; Thiele TE
Int Rev Neurobiol; 2017; 136():177-197. PubMed ID: 29056151
[TBL] [Abstract][Full Text] [Related]
15. Alcoholism: allostasis and beyond.
Koob GF
Alcohol Clin Exp Res; 2003 Feb; 27(2):232-43. PubMed ID: 12605072
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptides: opportunities for drug discovery.
Hökfelt T; Bartfai T; Bloom F
Lancet Neurol; 2003 Aug; 2(8):463-72. PubMed ID: 12878434
[TBL] [Abstract][Full Text] [Related]
17. Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse.
Jerlhag E
Pharmacol Ther; 2019 Apr; 196():1-14. PubMed ID: 30439457
[TBL] [Abstract][Full Text] [Related]
18. Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).
Rodriguez FD; Coveñas R
Curr Med Chem; 2017; 24(23):2528-2558. PubMed ID: 28302012
[TBL] [Abstract][Full Text] [Related]
19. Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides.
Ubaldi M; Bifone A; Ciccocioppo R
Curr Opin Neurobiol; 2013 Aug; 23(4):684-91. PubMed ID: 23648086
[TBL] [Abstract][Full Text] [Related]
20. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
Xu TR; Yang Y; Ward R; Gao L; Liu Y
Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
